[HTML][HTML] IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections

J Slaats, J Ten Oever, FL van de Veerdonk… - PLoS …, 2016 - journals.plos.org
The host inflammatory response against infections is characterized by the release of pro-
inflammatory cytokines and acute-phase proteins, driving both innate and adaptive arms of …

Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view

W Schulte, J Bernhagen, R Bucala - Mediators of inflammation, 2013 - Wiley Online Library
Sepsis and septic shock are among the leading causes of death in intensive care units
worldwide. Numerous studies on their pathophysiology have revealed an imbalance in the …

Biomarkers of sepsis

JD Faix - Critical reviews in clinical laboratory sciences, 2013 - Taylor & Francis
Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection,
and it probably represents a pattern of response by the immune system to injury. A hyper …

Pyroptosis-induced inflammation and tissue damage

SO Vasudevan, B Behl, VA Rathinam - Seminars in immunology, 2023 - Elsevier
Pyroptosis is a programmed necrotic cell death executed by gasdermins, a family of pore-
forming proteins. The cleavage of gasdermins by specific proteases enables their pore …

Interleukin-1 and interleukin-1 antagonism

CA Dinarello - 1991 - ashpublications.org
The polypeptide cytokine interleukin-1 (IL-1) affects nearly every tissue and organ system. IL-
1 is the prototype of the pro-inflammatory cytokines in that it induces the expression of a …

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled …

CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk… - Jama, 1994 - jamanetwork.com
Objective.—To further define the safety and efficacy of recombinant human interleukin 1
receptor antagonist (rhIL-1ra) in the treatment of sepsis syndrome. Study Design …

Multiple organ failure pathophysiology and potential future therapy

EA Deitch - Annals of surgery, 1992 - journals.lww.com
Multiple organ failure (MOF) has reached epidemic proportions in most intensive care units
and is fast becoming the most common cause of death in the surgical intensive care unit …

[HTML][HTML] Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein

CJ Fisher Jr, JM Agosti, SM Opal… - … England Journal of …, 1996 - Mass Medical Soc
Background A recombinant, soluble fusion protein that is a dimer of an extracellular portion
of the human tumor necrosis factor (TNF) receptor and the Fc portion of IgG1 (TNFR: Fc) …

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

P Damas, D Ledoux, M Nys, Y Vrindts… - Annals of …, 1992 - ncbi.nlm.nih.gov
Forty critically ill surgical patients with documented infections were studied during their stay
in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of …

Dysregulation of in vitro cytokine production by monocytes during sepsis.

C Munoz, J Carlet, C Fitting, B Misset… - The Journal of …, 1991 - Am Soc Clin Investig
The production by monocytes of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1
beta), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF alpha) in intensive care unit …